cdmo.directory
← Compare landing

Boston Institute of Biotechnology, LLC vs ProBioGen AG

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bostonbib/probiogen

CategoryBoston Institute of Biotechnology, LLCProBioGen AG
Listed sitecdmocdmo
SummaryFull-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from cell line development through commercial-scale fill/finish.ProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Gene Therapy
  • Cell Therapy
  • Peptide
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters, Southborough, Massachusetts, United States
  • Headquarters, Berlin, Berlin, Germany
  • Office, Berlin, Berlin, Germany
CertificationsData not yet provided.
  • EMA · Identifier: GMP compliant
  • FDA · Identifier: GMP compliant
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.